vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Zeta Global Holdings Corp. (ZETA). Click either name above to swap in a different company.

Zeta Global Holdings Corp. is the larger business by last-quarter revenue ($394.6M vs $270.8M, roughly 1.5× HUTCHMED (China) Ltd). Zeta Global Holdings Corp. runs the higher net margin — 1.7% vs 0.7%, a 0.9% gap on every dollar of revenue. On growth, Zeta Global Holdings Corp. posted the faster year-over-year revenue change (25.4% vs -16.5%). Zeta Global Holdings Corp. produced more free cash flow last quarter ($60.9M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Zeta Global Holdings Corp. is an American marketing technology company which was founded in 2007. Zeta offers companies a suite of multichannel marketing tools focused on creating, maintaining, and monetizing customer relationships. The company went public on the New York Stock Exchange on June 10, 2021, at a US$1.7 billion valuation.

HCM vs ZETA — Head-to-Head

Bigger by revenue
ZETA
ZETA
1.5× larger
ZETA
$394.6M
$270.8M
HCM
Growing faster (revenue YoY)
ZETA
ZETA
+42.0% gap
ZETA
25.4%
-16.5%
HCM
Higher net margin
ZETA
ZETA
0.9% more per $
ZETA
1.7%
0.7%
HCM
More free cash flow
ZETA
ZETA
$57.5M more FCF
ZETA
$60.9M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
ZETA
ZETA
Revenue
$270.8M
$394.6M
Net Profit
$2.0M
$6.5M
Gross Margin
37.7%
59.5%
Operating Margin
-13.2%
4.5%
Net Margin
0.7%
1.7%
Revenue YoY
-16.5%
25.4%
Net Profit YoY
-83.6%
-57.1%
EPS (diluted)
$0.00
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
ZETA
ZETA
Q4 25
$270.8M
$394.6M
Q3 25
$337.2M
Q2 25
$277.7M
$308.4M
Q1 25
$324.5M
$264.4M
Q4 24
$314.7M
Q3 24
$268.3M
Q2 24
$305.7M
$227.8M
Q1 24
$194.9M
Net Profit
HCM
HCM
ZETA
ZETA
Q4 25
$2.0M
$6.5M
Q3 25
$-3.6M
Q2 25
$455.0M
$-12.8M
Q1 25
$11.9M
$-21.6M
Q4 24
$15.2M
Q3 24
$-17.4M
Q2 24
$25.8M
$-28.1M
Q1 24
$-39.6M
Gross Margin
HCM
HCM
ZETA
ZETA
Q4 25
37.7%
59.5%
Q3 25
60.5%
Q2 25
0.1%
62.1%
Q1 25
48.0%
60.9%
Q4 24
60.0%
Q3 24
60.6%
Q2 24
41.1%
60.0%
Q1 24
60.6%
Operating Margin
HCM
HCM
ZETA
ZETA
Q4 25
-13.2%
4.5%
Q3 25
2.6%
Q2 25
-1.3%
-1.7%
Q1 25
-5.0%
-6.1%
Q4 24
2.2%
Q3 24
-4.6%
Q2 24
-9.0%
-11.7%
Q1 24
-18.4%
Net Margin
HCM
HCM
ZETA
ZETA
Q4 25
0.7%
1.7%
Q3 25
-1.1%
Q2 25
163.8%
-4.2%
Q1 25
3.7%
-8.2%
Q4 24
4.8%
Q3 24
-6.5%
Q2 24
8.4%
-12.3%
Q1 24
-20.3%
EPS (diluted)
HCM
HCM
ZETA
ZETA
Q4 25
$0.00
$0.04
Q3 25
$-0.02
Q2 25
$0.52
$-0.06
Q1 25
$0.01
$-0.10
Q4 24
$0.10
Q3 24
$-0.09
Q2 24
$0.03
$-0.16
Q1 24
$-0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
ZETA
ZETA
Cash + ST InvestmentsLiquidity on hand
$1.4B
$319.8M
Total DebtLower is stronger
$93.2M
$197.1M
Stockholders' EquityBook value
$1.2B
$804.6M
Total Assets
$1.8B
$1.5B
Debt / EquityLower = less leverage
0.08×
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
ZETA
ZETA
Q4 25
$1.4B
$319.8M
Q3 25
$385.2M
Q2 25
$1.4B
$365.3M
Q1 25
$836.1M
$364.4M
Q4 24
$366.2M
Q3 24
$418.5M
Q2 24
$802.5M
$154.7M
Q1 24
$141.6M
Total Debt
HCM
HCM
ZETA
ZETA
Q4 25
$93.2M
$197.1M
Q3 25
$196.9M
Q2 25
$93.4M
$196.7M
Q1 25
$82.8M
$196.5M
Q4 24
$196.3M
Q3 24
$196.1M
Q2 24
$82.1M
$184.4M
Q1 24
$184.2M
Stockholders' Equity
HCM
HCM
ZETA
ZETA
Q4 25
$1.2B
$804.6M
Q3 25
$689.2M
Q2 25
$1.2B
$673.3M
Q1 25
$759.9M
$676.6M
Q4 24
$676.8M
Q3 24
$474.9M
Q2 24
$740.1M
$217.0M
Q1 24
$191.6M
Total Assets
HCM
HCM
ZETA
ZETA
Q4 25
$1.8B
$1.5B
Q3 25
$1.2B
Q2 25
$1.8B
$1.1B
Q1 25
$1.3B
$1.1B
Q4 24
$1.1B
Q3 24
$869.1M
Q2 24
$1.3B
$583.9M
Q1 24
$550.3M
Debt / Equity
HCM
HCM
ZETA
ZETA
Q4 25
0.08×
0.24×
Q3 25
0.29×
Q2 25
0.08×
0.29×
Q1 25
0.11×
0.29×
Q4 24
0.29×
Q3 24
0.41×
Q2 24
0.11×
0.85×
Q1 24
0.96×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
ZETA
ZETA
Operating Cash FlowLast quarter
$8.2M
$64.1M
Free Cash FlowOCF − Capex
$3.4M
$60.9M
FCF MarginFCF / Revenue
1.2%
15.4%
Capex IntensityCapex / Revenue
1.8%
0.8%
Cash ConversionOCF / Net Profit
4.21×
9.81×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$185.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
ZETA
ZETA
Q4 25
$8.2M
$64.1M
Q3 25
$57.9M
Q2 25
$-72.9M
$42.0M
Q1 25
$40.3M
$34.8M
Q4 24
$43.7M
Q3 24
$34.4M
Q2 24
$-39.8M
$31.1M
Q1 24
$24.7M
Free Cash Flow
HCM
HCM
ZETA
ZETA
Q4 25
$3.4M
$60.9M
Q3 25
$52.4M
Q2 25
$-82.2M
$39.7M
Q1 25
$32.5M
$32.1M
Q4 24
$35.4M
Q3 24
$29.5M
Q2 24
$-49.9M
$24.4M
Q1 24
$18.9M
FCF Margin
HCM
HCM
ZETA
ZETA
Q4 25
1.2%
15.4%
Q3 25
15.6%
Q2 25
-29.6%
12.9%
Q1 25
10.0%
12.1%
Q4 24
11.3%
Q3 24
11.0%
Q2 24
-16.3%
10.7%
Q1 24
9.7%
Capex Intensity
HCM
HCM
ZETA
ZETA
Q4 25
1.8%
0.8%
Q3 25
1.6%
Q2 25
3.3%
0.8%
Q1 25
2.4%
1.0%
Q4 24
2.6%
Q3 24
1.8%
Q2 24
3.3%
3.0%
Q1 24
3.0%
Cash Conversion
HCM
HCM
ZETA
ZETA
Q4 25
4.21×
9.81×
Q3 25
Q2 25
-0.16×
Q1 25
3.38×
Q4 24
2.87×
Q3 24
Q2 24
-1.54×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons